LPC 175 CONCLAVE TO BE HELD IN MUMBAI
The theme of the event is Future of Pharma: Challenges & Opportunities
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Hikal gets Brazilian GMP certification and US FDA EIR for Bangalore and Panoli facilities
Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a…
Parexel, Partex announce alliance to leverage AI, Big Data to accelerate drug discovery and…
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better…
CPHI Milan to be hosted at Fiera Milano and Lombardy Pharma Region for 2024
A company statement informed that the 2024 event is expected to see a record attendance, with a large number of international…
Venus Remedies launches its flagship R&D drug Elores in Oman
The antibacterial market in Oman is worth $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Glenmark gets ANDA approval for Tacrolimus Ointment, 0.03%
Glenmark’s Tacrolimus Ointment, 0.03%, will be distributed in the US by Glenmark Pharmaceuticals, US
Affordability is tied to quality
In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…
Lupin gets US FDA nod for Bromfenac Ophthalmic Solution, 0.09%; Metoprolol Succinate ER Tablets USP
Both products will be manufactured at Lupin’s Pithampur facility in India
IIT Guwahati researchers produce pluripotent stem cells from skin cells
iPSCs hold potential in stem cell therapy for the treatment of diseases like diabetes, cancer, paralysis, and Alzheimer's
Delayed payments to pharma MSMEs: A major challenge
Delayed payments put SMEs at a disadvantage compared to large size counterparts, inhibiting their ability to compete effectively…